The human 80S ribosome is the cellular nucleoprotein nanomachine in charge of protein synthesis that is profoundly affected during cancer transformation by oncogenic proteins and provides cancerous proliferating cells with proteins and therefore biomass. Indeed, cancer is associated with an increase in ribosome biogenesis and mutations in several ribosomal proteins genes are found in ribosomopathies, which are congenital diseases that display an elevated risk of cancer. Ribosomes and their biogenesis therefore represent attractive anti-cancer targets and several strategies are being developed to identify efficient and specific drugs. Homoharringtonine (HHT) is the only direct ribosome inhibitor currently used in clinics for cancer treatments, although many classical chemotherapeutic drugs also appear to impact on protein synthesis. Here we review the role of the human ribosome as a medical target in cancer, and how functional and structural analysis combined with chemical synthesis of new inhibitors can synergize. The possible existence of oncoribosomes is also discussed. The emerging idea is that targeting the human ribosome could not only allow the interference with cancer cell addiction towards protein synthesis and possibly induce their death but may also be highly valuable to decrease the levels of oncogenic proteins that display a high turnover rate (MYC, MCL1). Cryo-electron microscopy (cryo-EM) is an advanced method that allows the visualization of human ribosome complexes with factors and bound inhibitors to improve our understanding of their functioning mechanisms mode. Cryo-EM structures could greatly assist the foundation phase of a novel drug-design strategy. One goal would be to identify new specific and active molecules targeting the ribosome in cancer such as derivatives of cycloheximide, a well-known ribosome inhibitor.
Electronic waste is becoming a growing global pollution issue due to short device lifespans and insufficient safe disposal methods. Hazardous metals like arsenic and mercury from electronic waste harm both the environment and human health. Recycling processes remain underdeveloped, requiring new eco-friendly solutions. This paper reports on the synthesis and properties of the cationic surfactants ammonium terthiophene (CTT) and 3,4-propylene-dioxythiophene (C-ProDOT), which may have potential use in organic electronics. Ecotoxicological tests showed no significant long-term toxicity and medium-to-high biodegradability, which are keys for environmental protection. These surfactants also displayed selective bacterial adhesion, making them candidates for bionic devices. Life cycle assessment revealed higher energy use and ecotoxicity for C-ProDOT than CTT, underscoring the need for sustainable chemical design.
We report the synthesis of a new class of main-chain polysulfate photosensitizers featuring aggregation-induced emission (AIE) activity. These polymers were prepared through Sulfur(VI) Fluoride Exchange (SuFEx) click polymerization between a bisfluorosulfate-functionalized AIE monomer and various phenolic derivatives. The resulting networks combine excellent thermal stability with strong solid-state fluorescence and extended π-conjugation, enabling efficient absorption of visible light and robust photophysical performance. Under photoirradiation, the polysulfates generate singlet oxygen with high efficiency, which was successfully applied to the aerobic oxidation of thioanisole under green LED illumination. Their heterogeneous polymeric nature are promising candidates for sustainable photocatalysis and visible-light-driven transformations.